Moderna, Inc. (MRNA) Price and Market Data

Explore real-time Moderna, Inc. (MRNA) price, market cap, trading volume, and price changes. View the live price chart and key reference data.

MR
Moderna, Inc.
MRNA
Stock
NasdaqGS

Price

$204.75
-0.99% since yesterday
$206.8 previous close

Market Cap

$82.846B
$206.8 open

Volume & Range

$2.98M
$208.68 24h high
$199.2 24h low

VWAP

N/A
Volume-weighted average price

Moderna, Inc. price chart-14.57%1M

Next MRNA earnings

February 12, 2027in 86 days

Q4 2026 · Time not confirmed · Estimated · 3 more in the next 12 months

Calendar
Moderna, Inc. is a commercial-stage biotechnology company founded in 2010 that completed its initial public offering in December 2018. The company’s mRNA platform was quickly validated through its COVID-19 vaccine, which received authorization in the United States in December 2020. As of August 2025, Moderna had 35 mRNA development candidates in clinical studies. Its pipeline covers multiple therapeutic areas, including infectious diseases, oncology, cardiovascular disease, and rare genetic disorders.

Reference

Exchange
NasdaqGS
Sector
Biotechnology
Employees
4,700
Market cap
$82.846B
Currency
USD

Hyperliquid HIP-3 markets